SIRT7 and familial pancreatic carcinoma: The therapeutic modulation of SIRT7 through inhibitors that stabilize its expression and block pro-tumorigenic pathways may provide a novel approach to controlling pancreatic cancer progression, particularly in cases resistant to conventional therapies.